Mostrando 1 - 20 Resultados de 81 Para Buscar '"Leishmaniasis"', tiempo de consulta: 0.56s Limitar resultados
  1. 1
    “…Leishmania aethiopica is the main causative species for cutaneous leishmaniasis (CL) in Ethiopia. Despite its considerable burden, L. aethiopica has been one of the most neglected Leishmania species. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Cutaneous Leishmaniasis Due to Leishmania aethiopica
  2. 2
    “…Half a million new cases of visceral leishmaniasis occur each year, and 10% of these are fatal. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Visceral Leishmaniasis: New Health Tools Are Needed
  3. 3
    “…Visceral Leishmaniasis (VL) is an important protozoan opportunistic disease in HIV patients in endemic areas. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Visceral Leishmaniasis and HIV Coinfection in East Africa
  4. 4
    “…Visceral leishmaniasis is a neglected tropical disease endemic in East Africa where improved patient-adapted treatments are needed. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The Leishmaniasis East Africa Platform (LEAP): strengthening clinical trial capacity in resource-limited countries to deliver new treatments for visceral leishmaniasis
  5. 5
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Visceral Leishmaniasis and HIV Coinfection: Time for Concerted Action
  6. 6
    “…Thus, targeting L-arginine metabolism might be a promising therapeutic strategy against leishmaniasis, especially in children and young adults.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Age-Related Alteration of Arginase Activity Impacts on Severity of Leishmaniasis
  7. 7
    “…BACKGROUND: Cutaneous leishmaniasis (CL) is endemic in the highlands of Ethiopia, and almost always caused by Leishmania aethiopica. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    A zoonotic focus of cutaneous leishmaniasis in Addis Ababa, Ethiopia
  8. 8
    “…BACKGROUND: Visceral leishmaniasis is a parasitic disease associated with high mortality. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Arginase Activity in the Blood of Patients with Visceral Leishmaniasis and HIV Infection
  9. 9
    “…BACKGROUND: Cutaneous leishmaniasis is a vector-borne disease that is in Ethiopia mainly caused by the parasite Leishmania aethiopica. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Local Increase of Arginase Activity in Lesions of Patients with Cutaneous Leishmaniasis in Ethiopia
  10. 10
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Correction: Arginase Activity in the Blood of Patients with Visceral Leishmaniasis and HIV Infection
  11. 11
    “…BACKGROUND: Visceral leishmaniasis (VL) can be fatal without timely diagnosis and treatment. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Development and comparative evaluation of two antigen detection tests for Visceral Leishmaniasis
  12. 12
    “…Leishmania aethiopica is the etiological agent of cutaneous leishmaniasis (CL) in Ethiopia and can cause severe and complicated cases such as diffuse CL (DCL), mucocutaneous leishmaniasis or extensive CL, requiring systemic treatment. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Treatment of Cutaneous Leishmaniasis Caused by Leishmania aethiopica: A Systematic Review
  13. 13
    “…BACKGROUND: Visceral leishmaniasis (VL), a vector-borne disease caused by species of the L.donovani complex, has (re)-emerged in Ethiopia during the last two decades and is currently of increasing public health concern. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Epidemiology of visceral leishmaniasis in Shebelle Zone of Somali Region, eastern Ethiopia
  14. 14
    “…The underlying mechanisms resulting in the profound immune suppression characteristic of human visceral leishmaniasis (VL) are not fully understood. Here, we tested the hypothesis that arginase, an enzyme associated with immunosuppression, is higher in patients with VL and contributes to impaired T cell responses. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Arginase Activity - A Marker of Disease Status in Patients with Visceral Leishmaniasis in Ethiopia
  15. 15
    “…Identifying the hosts that contribute most towards infection of the vectors is crucial for understanding the transmission dynamics, and planning targeted intervention policy of visceral leishmaniasis as well as other vector borne infectious diseases (e.g., West Nile Fever).…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Quantifying the Contribution of Hosts with Different Parasite Concentrations to the Transmission of Visceral Leishmaniasis in Ethiopia
  16. 16
    “…Visceral leishmaniasis (VL) is a neglected tropical disease that affects the poorest communities and can cause substantial morbidity and mortality. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Disease severity in patients with visceral leishmaniasis is not altered by co-infection with intestinal parasites
  17. 17
    “…The balance between T helper (Th) 1 and Th2 cell responses is a major determinant of the outcome of experimental leishmaniasis, but polarized Th1 or Th2 responses are not sufficient to account for healing or nonhealing. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Local Suppression of T Cell Responses by Arginase-Induced L-Arginine Depletion in Nonhealing Leishmaniasis
  18. 18
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Visceral Leishmaniasis Relapse in HIV Patients—A Role for Myeloid-Derived Suppressor Cells?
  19. 19
    “…BACKGROUND: Visceral leishmaniasis (VL, also called ‘’kala-azar”), is a life threatening neglected tropical infectious disease which mainly affects the poorest of the poor. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Risk factors of visceral leishmaniasis: a case control study in north-western Ethiopia
  20. 20
    “…BACKGROUND: A recent study has shown that treatment of visceral leishmaniasis (VL) with the standard dose of 15 mg/kg/day of paromomycin sulphate (PM) for 21 days was not efficacious in patients in Sudan. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Paromomycin for the Treatment of Visceral Leishmaniasis in Sudan: A Randomized, Open-Label, Dose-Finding Study
Herramientas de búsqueda: RSS